Caption Management, LLC Heron Therapeutics, Inc. Transaction History

Caption Management, LLC

  • $10.8 Billion
  • Q3 2025

A detailed history of Caption Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 2,000,000 shares of HRTX stock, worth $2.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,000,000
Previous 1,505,900 32.81%
Holding current value
$2.2 Million
Previous $3.12 Million 17.87%
% of portfolio
0.02%
Previous 0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$1.21 - $2.23 $888,499 - $1.64 Million
734,297 New
734,297 $939,000
Q2 2022

Aug 15, 2022
SELL
$2.3 - $6.29 $83,950 - $229,585
-36,500 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$4.63 - $9.94 $1.45 Million - $3.11 Million
-312,610 Reduced 89.54%
36,500 $209,000
Q4 2021

Feb 11, 2022
BUY
$8.35 - $12.6 $2.92 Million - $4.4 Million
349,110 New
349,110 $3.19 Million
Q2 2021

Aug 16, 2021
SELL
$13.27 - $18.48 $490,990 - $683,760
-37,000 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$14.49 - $20.72 $657,846 - $940,688
-45,400 Reduced 55.1%
37,000 $600,000
Q1 2020

May 15, 2020
BUY
$10.23 - $24.56 $842,952 - $2.02 Million
82,400 New
82,400 $967,000
Q4 2019

Feb 13, 2020
SELL
$17.42 - $26.61 $1.37 Million - $2.09 Million
-78,650 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$16.36 - $21.39 $877,714 - $1.15 Million
53,650 Added 214.6%
78,650 $1.46 Million
Q2 2019

Aug 13, 2019
SELL
$16.93 - $26.22 $206,546 - $319,884
-12,200 Reduced 32.8%
25,000 $465,000
Q1 2019

May 14, 2019
BUY
$23.15 - $28.34 $861,180 - $1.05 Million
37,200 New
37,200 $909,000

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $131M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email